Alphatec Holdings (ATEC) Cash from Investing Activities Growth (3y) (2013 - 2026)
Alphatec Holdings (ATEC) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | -17.67% |
| 10 | Alphatec Holdings | 1.45 Bn | 1.34 Bn | 154.10 Mn | 33.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.01% |
| Mar 31, 2026 | -5.76% |
| Dec 31, 2025 | -1.98% |
| Sep 30, 2025 | 3.85% |
| Jun 30, 2025 | 5.47% |
| Mar 31, 2025 | 4.68% |
| Dec 31, 2024 | 42.78% |
| Sep 30, 2024 | -15.45% |
| Jun 30, 2024 | 28.66% |
| Mar 31, 2024 | -8.95% |
| Dec 31, 2023 | -36.81% |
| Sep 30, 2023 | -53.93% |
| Jun 30, 2023 | -159.00% |
| Mar 31, 2023 | -85.63% |
| Dec 31, 2022 | -78.81% |
| Sep 30, 2022 | -32.49% |
| Jun 30, 2022 | -75.87% |
| Mar 31, 2022 | -132.41% |
| Dec 31, 2021 | -79.34% |
| Sep 30, 2021 | -92.22% |